Polpharma to produce generic version of Viagra

Polpharma will produce it under its own brand name on license from Warsaw-based Pharmaceuticals Institute, which came up with a new way of synthesizing sildenafil. "It is not a very i mportant drug for us, as the market for Viagra in Poland is not large and amounts to $3 million annually. However, it will continue to grow and we plan to win in terms of price, as the original drug is expensive," explained Polpharma president Pavel Mirovsky. After launching the sales of the drug, almost for sure Polpharma will be sued by Pfizer which invented Viagra. "If Polpharma introduces a generic drug based on our medicine, then we will consider our options. We expect other market players to act according to the law," said Pfizer Polska's representative Adam Linka. (Puls Biznesu, pp. 1, 7) M.M.